Allscripts Healthcare Solutions, INC.: directors' dealings · United States · SEC (Form 4)

About Allscripts Healthcare Solutions, INC.

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (ticker MDRX) is a U.S.-based healthcare technology company listed on the NASDAQ in the United States. The company is best known by its former name, Allscripts; it officially changed its corporate name to Veradigm Inc. effective January 1, 2023, while the MDRX ticker remained in use. Headquartered in Chicago, Illinois, the company has long been one of the recognizable U.S. players in healthcare IT. Incorporated in 2000, it grew over time through organic development and acquisitions into a software-and-data platform serving providers and other healthcare stakeholders. Its core business centers on healthcare information technology solutions, including electronic health records (EHRs), practice management, patient engagement, data connectivity, analytics, and revenue-cycle-related services. Historically, the company served physicians, medical groups, hospitals, health systems, payers, and life sciences companies. After portfolio simplification and asset divestitures, the business became more focused on connectivity, healthcare data, and network-based solutions, with a strategic emphasis on interoperable platforms and actionable data rather than stand-alone clinical software alone. From a competitive standpoint, MDRX operates in a highly fragmented but fiercely competitive market dominated by a handful of large EHR vendors and numerous specialists in patient engagement, revenue cycle management, interoperability, and analytics. Its positioning relies on the combination of software, network reach, and data capabilities. The company highlights the Veradigm Network, a community of solutions and partners designed to connect providers, payers, and life sciences organizations and convert real-world healthcare data into decision support and commercial insight. Key products and services include EHR platforms, physician office solutions, patient communication tools, integration and analytics capabilities, and offerings tailored to the provider, payer, and life sciences markets. Geographically, the business remains primarily concentrated in the United States, although the company has historically had selective international relationships and a broader technology footprint depending on acquisitions and business lines at the time. Recent milestones have been dominated by strategic restructuring. In 2022, the company completed the sale of its Hospital and Large Physician Practices business to Constellation Software, a major portfolio-shaping move. In 2023, the corporate name change to Veradigm formally marked the end of the Allscripts identity and the start of a more data-driven branding strategy. More recently, the company has continued to emphasize its data network, connectivity capabilities, and healthcare analytics positioning while operating in an environment shaped by regulatory complexity, industry consolidation, cybersecurity risk, and ongoing pressure to improve billing, claims, and care-coordination workflows.